AKT1 and cancer: In this research, we have meticulously delineated the signaling pathways most significantly associated with the therapeutic targets of AM and LA drug pairs, identifying the MAPK pathway as the most closely related, followed by the PI3K–AKT signaling pathway, calcium signaling pathway, and pathways involved in immune-inflammatory regulation and cancer.